This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Columbia University, University of Illinois. Active years: 2016-2020.
Company Filing History:
2 out of 2,551 
2 out of 2,421 
Years Active: 2016-2020
Title: Isaac Thomas Schiefer: Innovator in Cysteine Protease Inhibitors
Introduction
Isaac Thomas Schiefer is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of biochemistry, particularly in the development of cysteine protease inhibitors. With a total of 2 patents, Schiefer's work focuses on innovative solutions for neurodegenerative diseases.
Latest Patents
Schiefer's latest patents include groundbreaking inventions related to cysteine protease inhibitors. The first patent provides novel cysteine protease inhibitors and compositions comprising these derivatives. It also outlines methods for treating neurodegenerative diseases through the administration of these inhibitors. In some embodiments, the cysteine protease inhibitors are identified as calpain inhibitors. This innovative approach aims to offer new therapeutic options for patients suffering from neurodegenerative conditions.
Career Highlights
Throughout his career, Isaac Thomas Schiefer has worked with prestigious institutions such as Columbia University and the University of Illinois. His research has contributed to advancements in the understanding and treatment of various diseases, showcasing his commitment to scientific innovation.
Collaborations
Some of Schiefer's notable coworkers include Gregory R J Thatcher and Ottavio Arancio. Their collaborative efforts have further enhanced the impact of his research in the scientific community.
Conclusion
Isaac Thomas Schiefer's contributions to the field of cysteine protease inhibitors highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for improving treatment options for neurodegenerative diseases.